YCharts, a startup that provides stock research, tools and analysis, has raised $3.25 million in Series B financing led by investment research company, Morningstar with participation from existing investors including the Hyde Park Angels, I2A, and others. This brings YCharts’ total funding to $4.75 million.

YCharts provides free stock analysis tools and charts that give investors a quick, comprehensive long-term outlook on their holdings. The site lets them understand the real value of their holdings in the long run by comparing dividend yields, total returns (not offered by Yahoo Finance) and around 75 other metrics, with the ability to compare against other holdings.

The beauty of YCharts is that it digs into past long-tail data that’s publicly available from a variety of sources, such as P/E ratios, R&D spending, or cash flows, and graphs these over time. YCharts, which does not offer opinion-based analysis, seeks to provide investors with comprehensive, objective information on the companies behind the stocks, allowing them to make the most accurate decision for their portfolios.

YCharts currently offers three products; YCharts.com, YCharts Pro and its chart creator tool for third-party sites, journalists and bloggers. For a monthly fee, Pro users gain access to YCharts’ quantitative analysis strategies that objectively rate the stocks covered. The service has grown from 30,000 users to more than 400,000 users in slightly more than a year.

The funding will be used to build out the startp’s team, scale infrastructure, increase marketing efforts and expand the scope of its financial research and analytics.

Crunchbase

• YCHARTS

Company: YCharts

Website: ycharts.com

Launch Date: January 2009

Funding: $4.75M

Fundamental research and empirical data drives all portfolio strategies and stock ratings for YCharts and YCharts Pro. Our team performs extensive studies of historical factors that tend to predict future returns for growth and value stocks. We provide investors with transparent information that has been proven to beat the markets. Pro automates a lot of the research that professional analysts provide but we don’t have the same potential conflicts of interest. Our research and others have proven that equity...

Learn more